As of 2025-10-27, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 24.88 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.00 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 2387.8%.
The range of the Relative Valuation is 12.76 - 36.38 USD.
| Range | Selected | |
| Trailing P/E multiples | 13.7x - 23.7x | 18.7x |
| Forward P/E multiples | 14.7x - 18.9x | 16.8x |
| Fair Price | 12.76 - 36.38 | 24.88 |
| Upside | 1176.1% - 3537.9% | 2387.8% |
| Date | P/E |
| 2025-10-13 | 1.61 |
| 2025-10-09 | 1.72 |
| 2025-10-03 | 3.22 |
| 2025-10-02 | 3.22 |
| 2025-09-26 | 2.90 |
| 2025-09-25 | 3.03 |
| 2025-09-19 | 3.62 |
| 2025-09-18 | 3.29 |
| 2025-09-15 | 4.00 |
| 2025-09-12 | 3.45 |
| 2025-09-11 | 3.44 |
| 2025-09-10 | 3.45 |
| 2025-09-08 | 3.45 |
| 2025-09-05 | 3.25 |
| 2025-09-04 | 3.30 |
| 2025-09-02 | 3.32 |
| 2025-08-28 | 3.32 |
| 2025-08-20 | 3.42 |
| 2025-08-19 | 3.41 |
| 2025-08-11 | 3.44 |
| 2025-08-08 | 3.42 |
| 2025-08-06 | 3.42 |
| 2025-08-01 | 3.42 |
| 2025-07-22 | 3.96 |